The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DREAMM-7 study of belantamab mafodotin plus bortezomib and dexamethasone (BVd) vs daratumumab plus bortezomib and dexamethasone (DVd) in relapsed/refractory multiple myeloma (RRMM): A subgroup analysis in patients (pts) with high-risk cytogenetic (HRC) features.
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Kite, a Gilead company; Pfizer; Regeneron; Roche/Genentech; Stemline Therapeutics; Takeda
 
Pawel Robak
No Relationships to Disclose
 
Marek Hus
No Relationships to Disclose
 
Chengcheng Fu
No Relationships to Disclose
 
Vera Zherebtsova
No Relationships to Disclose
 
Christopher Ward
Leadership - Education Chair ISTH Congress planning Chair
Honoraria - Alexion Pharmaceuticals; AstraZeneca/UK; Bayer; CSL Limited; Drivetime Radio; GlaxoSmithKline
 
P. Joy Ho
Consulting or Advisory Role - Australasian Leukemia and Lymphoma groups
Research Funding - Novartis
 
Roman Hajek
Honoraria - Amgen; BMSi; Celgene; Janssen; PharmaMar; Takeda
Consulting or Advisory Role - Abbvie; Amgen; BMSi; Celgene; GlaxoSmithKline; Janssen; Novartis; Oncopeptides; PharmaMar; Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Takeda
Other Relationship - Amgen (Inst); BMSi (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Takeda (Inst)
 
Kihyun Kim
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; GlaxoSmithKline; Johnson & Johnson
Research Funding - Bristol-Myers Squibb; Johnson & Johnson; Sanofi
 
Meletios Dimopoulos
Honoraria - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb/Celgene; Janssen; Takeda
 
Claudio Cerchione
Stock and Other Ownership Interests - GlaxoSmithKline
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; BeiGene; Bristol-Myers Squibb; GlaxoSmithKline; GlycoMimetics; ImmunoGen; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Menarini; Oncopeptides; Pfizer; Sanofi; SERVIER; Stemline Therapeutics; Stemline Therapeutics; Takeda
 
Nicholas Pirooz
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Astrid McKeown
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Chee Paul Lin
Employment - GlaxoSmithKline
 
Hena Baig
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Lydia Eccersley
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Sumita Roy-Ghanta
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Joanna Opalinska
Employment - GlaxoSmithKline
Leadership - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - Blenrep related patents
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Vania Hungria
Consulting or Advisory Role - Abbvie; Amgen; BMS Brazil; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Sanofi; Takeda
Speakers' Bureau - Abbvie; Amgen; BMS Brazil; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi; Takeda